BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luczak M, Suszynska-Zajczyk J, Marczak L, Formanowicz D, Pawliczak E, Wanic-Kossowska M, Stobiecki M. Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease. Int J Mol Sci 2016;17:E631. [PMID: 27144566 DOI: 10.3390/ijms17050631] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zmienko A, Marszalek-Zenczak M, Wojciechowski P, Samelak-Czajka A, Luczak M, Kozlowski P, Karlowski WM, Figlerowicz M. AthCNV: A Map of DNA Copy Number Variations in the Arabidopsis Genome. Plant Cell 2020;32:1797-819. [PMID: 32265262 DOI: 10.1105/tpc.19.00640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
2 Tracz J, Handschuh L, Lalowski M, Marczak Ł, Kostka-Jeziorny K, Perek B, Wanic-Kossowska M, Podkowińska A, Tykarski A, Formanowicz D, Luczak M. Proteomic Profiling of Leukocytes Reveals Dysregulation of Adhesion and Integrin Proteins in Chronic Kidney Disease-Related Atherosclerosis. J Proteome Res 2021;20:3053-67. [PMID: 33939431 DOI: 10.1021/acs.jproteome.0c00883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jirak P, Stechemesser L, Moré E, Franzen M, Topf A, Mirna M, Paar V, Pistulli R, Kretzschmar D, Wernly B, Hoppe UC, Lichtenauer M, Salmhofer H. Clinical implications of fetuin-A. Adv Clin Chem 2019;89:79-130. [PMID: 30797472 DOI: 10.1016/bs.acc.2018.12.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
4 Małecki P, Tracz J, Łuczak M, Figlerowicz M, Mazur-Melewska K, Służewski W, Mania A. Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study. Expert Rev Proteomics 2020;17:623-32. [PMID: 32921203 DOI: 10.1080/14789450.2020.1810020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Małecki P, Mania A, Tracz J, Łuczak M, Mazur-Melewska K, Figlerowicz M. Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children. J Clin Exp Hepatol 2021;11:646-53. [PMID: 34866842 DOI: 10.1016/j.jceh.2021.03.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gryszczyńska B, Formanowicz D, Budzyń M, Wanic-Kossowska M, Pawliczak E, Formanowicz P, Majewski W, Strzyżewski KW, Kasprzak MP, Iskra M. Advanced Oxidation Protein Products and Carbonylated Proteins as Biomarkers of Oxidative Stress in Selected Atherosclerosis-Mediated Diseases. Biomed Res Int 2017;2017:4975264. [PMID: 28884122 DOI: 10.1155/2017/4975264] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
7 Jackowiak P, Lis A, Luczak M, Stolarek I, Figlerowicz M. Functional characterization of RNA fragments using high-throughput interactome screening. J Proteomics 2019;193:173-83. [PMID: 30339940 DOI: 10.1016/j.jprot.2018.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Marczak L, Idkowiak J, Tracz J, Stobiecki M, Perek B, Kostka-Jeziorny K, Tykarski A, Wanic-Kossowska M, Borowski M, Osuch M, Formanowicz D, Luczak M. Mass Spectrometry-Based Lipidomics Reveals Differential Changes in the Accumulated Lipid Classes in Chronic Kidney Disease. Metabolites 2021;11:275. [PMID: 33925471 DOI: 10.3390/metabo11050275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gryszczyńska B, Budzyń M, Formanowicz D, Wanic-Kossowska M, Formanowicz P, Majewski W, Iskra M, Kasprzak MP. Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid. J Clin Med 2020;9:E1416. [PMID: 32397681 DOI: 10.3390/jcm9051416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Podkowińska A, Formanowicz D. Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease. Antioxidants (Basel) 2020;9:E752. [PMID: 32823917 DOI: 10.3390/antiox9080752] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
11 Dytfeld D, Luczak M, Wrobel T, Usnarska-Zubkiewicz L, Brzezniakiewicz K, Jamroziak K, Giannopoulos K, Przybylowicz-Chalecka A, Ratajczak B, Czerwinska-Rybak J, Nowicki A, Joks M, Czechowska E, Zawartko M, Szczepaniak T, Grzasko N, Morawska M, Bochenek M, Kubicki T, Morawska M, Tusznio K, Jakubowiak A, Komarnicki MA. Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy. Oncotarget 2016;7:56726-36. [PMID: 27527861 DOI: 10.18632/oncotarget.11059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
12 Wasiak S, Tsujikawa LM, Halliday C, Stotz SC, Gilham D, Jahagirdar R, Kalantar-Zadeh K, Robson R, Sweeney M, Johansson JO, Wong NC, Kulikowski E. Benefit of Apabetalone on Plasma Proteins in Renal Disease. Kidney Int Rep 2018;3:711-21. [PMID: 29854980 DOI: 10.1016/j.ekir.2017.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
13 Tracz J, Luczak M. Applying Proteomics and Integrative "Omics" Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis. Int J Mol Sci 2021;22:7492. [PMID: 34299112 DOI: 10.3390/ijms22147492] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Pejchinovski M, Mischak H. Clinical Proteomics in Kidney Disease: From Discovery to Clinical Application. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2017;38:39-54. [PMID: 29668468 DOI: 10.2478/prilozi-2018-0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Vianello E, Kalousová M, Dozio E, Tacchini L, Zima T, Corsi Romanelli MM. Osteopontin: The Molecular Bridge between Fat and Cardiac-Renal Disorders. Int J Mol Sci 2020;21:E5568. [PMID: 32759639 DOI: 10.3390/ijms21155568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Toualbi LA, Mounir A, Wafa B, Medina A, Abderrezak K, Chahine T, Henni C, Abdelghani B, Atmane S. Implications of advanced oxidation protein products and vitamin E in atherosclerosis progression. Arch Med Sci Atheroscler Dis 2021;6:e135-44. [PMID: 34381915 DOI: 10.5114/amsad.2021.107823] [Reference Citation Analysis]
17 Parrish AR. Advances in Chronic Kidney Disease. Int J Mol Sci 2016;17:E1314. [PMID: 27529223 DOI: 10.3390/ijms17081314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]